TITLE 6. CRIMINAL JUSTICE AND CORRECTIONS
Rules Relating to Compulsory Minimum Training Standards for Jailors or Custodial Officers, Courthouse and Courtroom Security Officers and Process Service Officers
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the Criminal Justice Services Board intends to consider
amending 6VAC20-50, Rules Relating to Compulsory Minimum Training Standards
for Jailors or Custodial Officers, Courthouse and Courtroom Security Officers
and Process Service Officers. The purpose of the proposed action is to
comprehensively review the regulation. Revisions to the regulation are intended
to remove dated terminology, clarify confusing language, correct inaccurate
Code of Virginia references, and standardize requirements for testing and
documentation.
This Notice of Intended Regulatory Action serves as the report of
the findings of the regulatory review pursuant to § 2.2-4007.1 of the Code
of Virginia.
The agency does not intend to hold a public hearing on the
proposed action after publication in the Virginia Register.
Statutory Authority: § 9.1-102 of the Code of Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Barbara Peterson-Wilson, Law Enforcement
Program Coordinator, Department of Criminal Justice Services, 1100 Bank Street,
Richmond, VA 23219, telephone (804) 225-4503, FAX (804) 786-0410, or email
barbara.peterson-wilson@dcjs.virginia.gov.
VA.R. Doc. No. R17-5020; Filed May 8, 2017, 2:09 p.m.
TITLE 12. HEALTH
Virginia Radiation Protection Regulations: Fee Schedule
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the State Board of Health intends to consider amending 12VAC5-490,
Virginia Radiation Protection Regulations: Fee Schedule. The purpose of the
proposed action is to amend the fee schedule used by (i) the X-Ray Program
(XRP) for device registrations and inspections and (ii) the Radioactive
Materials Program (RMP) for initial licensure and annual licensing renewal. The
XRP and RMP are fully supported by these fees, which have not increased since
2009. At that time, fees were sufficient to accommodate program and ancillary
business functions as they were supplemented by general funds allocated to the
Office of Radiological Health (ORH). Virginia entered into an agreement with the
U.S. Nuclear Regulatory Commission (NRC) on March 31, 2009, to assume the
responsibilities of regulating the use of radioactive materials in the
Commonwealth. 12VAC5-490 was promulgated at that time to supply the monetary
means for supporting the RMP by charging application and annual licensing fees.
In November 2014, the NRC's Integrated Materials Performance Evaluation Program
review team evaluated Virginia's RMP and found "the Program experienced a
backlog in inspections due, in part, to having a shortage of qualified staff to
complete inspections within the required timeframe." Since that time, the
RMP has hired and trained two new inspectors and completed the overdue
inspection backlog, thus avoiding monitoring, probation, or forfeiture. General
funds that were used to support ORH were abolished in 2015. Since that time,
the surplus accumulated between 2009 and 2015 has been used to support ORH and
is projected to be depleted in 2018. Neither receiving general funds nor
reducing staff is an option, thus the fee increase is the best choice to
maintain the XRP, the RMP, and associated NRC Agreement State status.
The agency does not intend to hold a public hearing on the
proposed action after publication in the Virginia Register.
Statutory Authority: § 32.1-229.1 of the Code of
Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Steve Harrison, Director, Division of
Radiological Health, Department of Health, 109 Governor Street, Richmond, VA
23219, telephone (804) 864-8151, FAX (804) 864-8155, or email
steve.harrison@vdh.virginia.gov.
VA.R. Doc. No. R17-5115; Filed April 26, 2017, 1:35 p.m.
TITLE 12. HEALTH
Peer Recovery Specialists
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the State Board of Behavioral Health and Developmental
Services intends to consider promulgating 12VAC35-250, Peer Recovery
Specialists. The purpose of the proposed action is to establish the
qualifications, education, and experience for peer recovery specialists to
ensure that individuals providing peer recovery services in Virginia's public
system of behavioral health services demonstrate a baseline of practical
knowledge. The availability of peer recovery specialist services is expected to
expand through the Virginia Medicaid Addiction and Recovery Treatment Services
(ARTS) new substance use disorder benefit. Under the ARTS benefit, peer support
services will be made available to Medicaid members effective July 1, 2017. Peer
support resources will be an integral component of community integration,
wellness, resiliency, and recovery.
The agency intends to hold a public hearing on the proposed
action after publication in the Virginia Register.
Statutory Authority: §§ 37.2-203 and 37.2-304 of
the Code of Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Ruth Anne Walker, Regulatory
Coordinator, Department of Behavioral Health and Developmental Services,
Jefferson Building, 1220 Bank Street, 11th Floor, Richmond, VA 23219, telephone
(804) 225-2252, FAX (804) 786-8623, or email
ruthanne.walker@dbhds.virginia.gov.
VA.R. Doc. No. R17-4808; Filed May 8, 2017, 4:30 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Regulations Governing the Licensure of Nurse Practitioners
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the Board of Nursing intends to consider amending 18VAC90-30,
Regulations Governing the Licensure of Nurse Practitioners and 18VAC90-40,
Regulations for Prescriptive Authority for Nurse Practitioners. The
purpose of the proposed action is to address the opioid abuse crisis in
Virginia. Regulations for the management of acute pain include requirements for
the evaluation of the patient, limitations on quantity and dosage, and medical
recordkeeping. Regulations for management of chronic pain include requirements
for evaluation and treatment, including a treatment plan, informed consent and
agreement, consultation with other providers, and medical recordkeeping.
Regulations for prescribing of buprenorphine include requirements for patient
assessment and treatment planning, limitations on prescribing the buprenorphine
mono-product (without naloxone), dosages, co-prescribing of other drugs,
consultation, and medical records for opioid addiction treatment.
The agency intends to hold a public hearing on the proposed
action after publication in the Virginia Register.
Statutory Authority: §§ 54.1-2400 and 54.1-2928.2
of the Code of Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Jay P. Douglas, R.N., Executive
Director, Board of Nursing, 9960 Mayland Drive, Suite 300, Richmond, VA
23233-1463, telephone (804) 367-4520, FAX (804) 527-4455, or email
jay.douglas@dhp.virginia.gov.
VA.R. Doc. No. R17-5096; Filed May 1, 2017, 2:23 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Regulations for Prescriptive Authority for Nurse Practitioners
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the Board of Nursing intends to consider amending 18VAC90-30,
Regulations Governing the Licensure of Nurse Practitioners and 18VAC90-40,
Regulations for Prescriptive Authority for Nurse Practitioners. The
purpose of the proposed action is to address the opioid abuse crisis in
Virginia. Regulations for the management of acute pain include requirements for
the evaluation of the patient, limitations on quantity and dosage, and medical
recordkeeping. Regulations for management of chronic pain include requirements
for evaluation and treatment, including a treatment plan, informed consent and
agreement, consultation with other providers, and medical recordkeeping.
Regulations for prescribing of buprenorphine include requirements for patient
assessment and treatment planning, limitations on prescribing the buprenorphine
mono-product (without naloxone), dosages, co-prescribing of other drugs,
consultation, and medical records for opioid addiction treatment.
The agency intends to hold a public hearing on the proposed
action after publication in the Virginia Register.
Statutory Authority: §§ 54.1-2400 and 54.1-2928.2
of the Code of Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Jay P. Douglas, R.N., Executive
Director, Board of Nursing, 9960 Mayland Drive, Suite 300, Richmond, VA
23233-1463, telephone (804) 367-4520, FAX (804) 527-4455, or email
jay.douglas@dhp.virginia.gov.
VA.R. Doc. No. R17-5096; Filed May 1, 2017, 2:23 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Regulations Governing the Practice of Optometry
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the Board of Optometry intends to consider amending 18VAC105-20,
Regulations Governing the Practice of Optometry. The purpose of the
proposed action is to consider deleting unnecessary or unenforceable rules,
limiting the number of times an applicant can take and fail the licensing
examination before additional education is necessary, and specifying the
evidence of continued competency required for licensure by endorsement and
reinstatement. For reinstatement of a lapsed license, the board will also
consider requiring evidence of any disciplinary or malpractice action, and if the
applicant is licensed in another state, the board will consider requiring
evidence of a current, unrestricted license.
The agency intends to hold a public hearing on the proposed
action after publication in the Virginia Register.
Statutory Authority: §§ 54.1-2400 and 54.1-3223 of the
Code of Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Leslie L. Knachel, Executive Director,
Board of Optometry, 9960 Mayland Drive, Suite 300, Richmond, VA 23233,
telephone (804) 367-4508, FAX (804) 527-4471, or email
leslie.knachel@dhp.virginia.gov.
VA.R. Doc. No. R17-5114; Filed April 26, 2017, 1:17 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Regulations Governing the Practice of Pharmacy
Notice of Intended Regulatory Action
Notice is hereby given in accordance with § 2.2-4007.01 of the
Code of Virginia that the Board of Pharmacy intends to consider amending 18VAC110-20,
Regulations Governing the Practice of Pharmacy. The purpose of the proposed
action is to authorize issuance of a controlled substances registration to (i)
persons who have been trained in the administration of naloxone in order to
possess and dispense the drug to persons receiving training and (ii) an entity
for the purpose of establishing a bona fide practitioner-patient relationship
for prescribing when treatment is provided by telemedicine in accordance with
federal rules. As applicable, regulations for controlled substances registrants
will be considered for amendment, including recordkeeping, security, and
storage requirements.
The agency intends to hold a public hearing on the proposed
action after publication in the Virginia Register.
Statutory Authority: § 54.1-2400 of the Code of
Virginia.
Public Comment Deadline: June 28, 2017.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4416, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
VA.R. Doc. No. R17-5048; Filed May 8, 2017, 8:27 a.m.